|
mendelian randomization |
10 |
|
bronchopulmonary dysplasia |
7 |
|
infant |
7 |
|
premature |
7 |
|
supplemental oxygen |
7 |
|
adolescents |
6 |
|
drug-target mendelian randomization |
6 |
|
hmgcr inhibitors |
6 |
|
pcsk9 inhibitors |
6 |
|
safety |
6 |
|
adolescent |
5 |
|
adolescent obesity |
5 |
|
cardiovascular diseases |
5 |
|
case-control study |
5 |
|
cohort studies |
5 |
|
covid-19 |
5 |
|
diet |
5 |
|
epidemiology |
5 |
|
genetics |
5 |
|
gut microbiome |
5 |
|
metabolomics |
5 |
|
birthweight |
4 |
|
hepcidin |
4 |
|
ace2 |
3 |
|
asthma |
3 |
|
birth cohort |
3 |
|
ferritin |
3 |
|
gestational diabetes mellitus |
3 |
|
gestational duration |
3 |
|
glycaemic traits |
3 |
|
glycemic traits |
3 |
|
growth |
3 |
|
insulin |
3 |
|
iron |
3 |
|
liver cirrhosis |
3 |
|
liver iron |
3 |
|
liver steatosis |
3 |
|
lung function |
3 |
|
maternal hyperglycaemia |
3 |
|
mediation |
3 |
|
type 2 diabetes |
3 |
|
children |
2 |
|
chronic obstructive pulmonary disease |
2 |
|
intrauterine exposures |
2 |
|
lipid profile |
2 |
|
respiratory organs - diseases - research |
2 |
|
smoking |
2 |
|
age |
1 |
|
bmi |
1 |
|
cardiometabolic risk factors |
1 |
|
dyslipidaemia |
1 |
|
gender |
1 |
|
iron metabolism |
1 |
|
obesity |
1 |
|
sleep |
1 |
|
soluble transferrin receptor |
1 |
|
sugar-sweetened beverages |
1 |
|
transferrin |
1 |
